Video-assisted thoracoscopic cardiac denervation of refractory ventricular arrhythmias and electrical storms: a single-center series
The combined treatment of beta-blockers with ablation and Implanted cardioverter defibrillation therapy, continues to be the mainstay treatment for ventricular arrhythmias (VAs). Despite treatment, some patients remain refractory. Recent studies have shown success rates using video-assisted thoracoscopic (VATS) cardiac denervation as an effective therapeutic option for these patients.
Case series presentation
During a period of three years, from 2015 through 2017, twenty patients (N = 20) failed traditional medical and interventional treatment for the management of ventricular arrhythmias and electrical storms. After remaining refractory, the patients were referred to our thoracic surgery department for a VATS based treatment. The patients all had ventricular arrhythmias and electrical storms secondary to different cardiomyopathies. The patients were refractory to combined medical (beta-blockers), Implanted Cardioverter defibrillation (ICD) and ablation therapy. All twenty patients agreed to surgery and were taken to cardiac denervation using a bilateral VATS approach by two thoracic surgeons at a single Cardiothoracic center. During the month prior to bilateral VATS denervation a combined total of twenty-nine (N = 29) ICD shocks were registered in addition to six (N = 6) cases of electrical storms averaging three (N = 3) shocks per day. Mean shocks per patient was 2.3. During the first three months following VATS, the patients had a 90% (N = 18/20) total resolution of ICD registered shocks, a 100% (N = 6/6) resolution of electrical storms, and a 92% (N = 11/12) resolution of shocks in patients having previous ablation therapy. No complications were documented following surgery except for one case of pneumothorax as a result of the procedure, and there were no peri-operative mortalities.
Bilateral thoracoscopic cardiac denervation can be a safe and seemingly effective therapeutic option for patients presenting with life-threatening refractory ventricular arrhythmias and electrical storms in a variety of cardiomyopathies including Chagas disease.
KeywordsVentricular arrhythmias Electrical storms Denervation Video-assisted thoracic surgery Chagas Implanted cardioverter defibrillator Sympathectomy
Implanted Cardioverter defibrillator
Video-assisted Thoracoscopic surgery
Thoracoscopic sympathectomy was first described in 1942, and the first clinical reports date back to 1961 by Estes and Izlar. Left cardiac denervation was first reported in 1971 by Moss and McDonald and the first case of video-assisted thoracoscopic left sympathectomy was reported by Reardon and colleagues in 2000 [1, 2, 3, 4]. Three years later Li and colleagues presented the first small case series [2, 3, 4]. During the last 5 years, VATS cardiac denervation has become an accepted treatment option for refractory ventricular arrhythmias secondary to ischemia, hereditary arrhythmias, channelopathies, and arrhythmias due to long-QT-syndrome (LQTS) [2, 3, 4, 5, 6]. Most studies show a 70–80% effectiveness within the first month to 1 year following VATS cardiac denervation [1, 2, 3, 4, 5, 6]. Although the majority of cases are left ventricular arrhythmias, right-sided VAs may also benefit from this treatment option.
The sympathetic nervous system regulates cardiac electrophysiology through interconnections between preganglionic axons in the sympathetic paravertebral chains. The preganglionic axons synapse on neurons within the stellate ganglion (fusion of the lower cervical C7 and T1 ganglia) and run through T2–T4 [2, 3, 4, 5, 6, 7, 8]. These interconnections are an important component in the generation of life-threatening ventricular arrhythmias. Because of this fusion at the stellate ganglion, it is believed that cardiac impulses and arrhythmias may be generated even from C7; effective antiarrhythmic VATS therefore requires proper dissection of the lower half of the stellate ganglion in order to achieve the desired results with cardiac denervation [3, 4, 5, 6, 7, 8, 9]. The treatment of ventricular arrhythmias aims to prevent degeneration of cardiac myocytes, prevent development of heart failure and sudden cardiac death. Catheter ablation therapy is indicated for patients presenting with uncontrolled non-sustained VTs, and sudden cardiac death may be prevented using implantable cardioverter defibrillators. Inappropriate shocks however, lead to cardiac myocyte damage in turn increasing the risk of sudden cardiac death [2, 3, 4, 5, 6, 7]. Patients who are unresponsive to combined medical (beta-blockers), ablation and ICD therapy and those presenting with electrical storms are considered candidates for a VATS based therapy [4, 5, 6, 7, 8, 9, 10]. This manuscript describes a series of twenty patients having had bilateral VATS cardiac denervation for refractory ventricular arrhythmias.
Case series presentation
Patient Characteristics and Results
During the month prior to VATS denervation a combined total of twenty-nine (N = 29) ICD shocks were registered in addition to six (N = 6) cases of electrical storms which averaged three (N = 3) shocks daily. Total mean shocks per patient was 2.3 for an approximated 47 total registered shocks prior to surgery. During the first three months following VATS, the patients had a 90% (N = 18/20) total resolution of ICD registered shocks, a 100% (N = 6/6) resolution of electrical storms, and a 92% (11/12) resolution of ICD registered shocks in patients with previous ablation therapy. The follow-up period varied from one to nine months, during which a total of four (N = 4) ICD registered shocks were documented showing complete resolution in 80% (N = 16) of patients during this time frame. Two patients each had one (N = 1) shock within the week post-op, one patient had a single (N = 1) shock at three months post-op, and another patient had one (N = 1) shock at seven months post-op. During the first three months post VATS, only two (N = 2) registered ICD shocks were reported in all patients showing an overall 90% (N = 18) success rate along with complete resolution of electrical storms 100% (N = 6/6). A total number of pre-VATS shocks of (N = 47) including six (N = 6) cases of electrical storms were reduced to only two (N = 2) shocks during the first 3 months following VATS and complete resolution of electrical storms during the entire follow-up period. All four (N = 4) registered ICD shocks after VATS denervation in all twenty patients were VTs, no new VFs or electrical storms were registered. Results are summarized in Table 1.
The twelve (N = 12) patients remaining refractory following ablation therapy had a 92% (N = 11/12) resolution of ICD registered shocks during the first three months following VATS. Of the nine (N = 9) patients with refractory VAs due to Chagas disease, five (N = 5) had electrical storms and the other four (N = 4) patients had a total of eight (N = 8) registered ICD shocks during the month prior to VATS. Only one (N = 1) shock was registered during the first three months following VATS for an 89% (N = 8/9) resolution and complete resolution of electrical storms 100% (N = 5/5). Seven (N = 7) patients had refractory VAs secondary to Ischemic cardiomyopathy, of which one (N = 1) patient presented with electrical storms and the other six (N = 6) had a total of thirteen (N = 13) registered ICD shocks during the month prior to VATS. During follow-up only one (N = 1) shock was registered for a success rate of 86% (N = 6/7) as well as complete resolution of electrical storms 100% (N = 1/1). The three (N = 3) patients with refractory VAs secondary to dilated cardiomyopathy had a total of six (N = 6) registered shocks during the month prior to intervention. During the month following VATS, there was complete resolution of registered ICD shocks, 100% (N = 3/3) success. The one patient with LQTS had two (N = 2) registered shocks prior to VATS and none during follow-up, 100% (N = 1/1) resolution.
Complications using VATS denervation include Horner syndrome, nocturnal anisocoria, and compensatory hyperhidrosis. These complications can be prevented by avoiding the use of electrocautery, and properly dividing the lower half of the stellate ganglion [11, 12, 13, 14]. None of these were reported in our patients, and no significant neuropathic pain was observed during the post-op period. One patient needed a chest tube due to pneumothorax secondary to the procedure and one patient died at 3 months post-op due to the natural course of Chagas disease. One male patient did not have an ICD and post-op follow-up was conducted through symptom referral.
Immediate response to VATS cardiac denervation can be evaluated comparing pre-surgery to post-operative ICD shocks. Recent reports and series show positive results using VATS cardiac denervation in both bilateral as well as unilateral (left sided only) approaches. Studies show a drop of 93% in ICD shocks and a reduction of electrical storms from 38 to 14% [8, 9, 10, 11, 12, 13]. Some authors like Schwartz prefer a left-sided only approach arguing the dominance of the left sympathetic innervation. The left ventricle contributes to a significant catecholaminergic stimulus in the generation of refractory arrhythmias especially in long-QT syndrome. Authors like Ajijola consider a left-sided only approach ineffective in 50% of cases which later require an additional right-sided sympathectomy to effectively control VAs, predominantly in structural cardiomyopathies [12, 13, 14]. Richardson and colleagues reported a series of 7 patients with refractory VAs (median of 1 episode of sustained VA per-month) having no VAs during 7 months following VATS denervation [12, 13, 14, 15].
In this series the number of ICD registered shocks during the month prior to VATS was compared to those during the month following cardiac denervation. During the first three months following VATS cardiac denervation, the patients had a 90% (18/20) total resolution of ICD registered shocks, a 100% (6/6) resolution of electrical storms, and a 92% (11/12) resolution of ICD registered shocks in patients with previous ablation therapy. This study showed an overall immediate short-term post-op success rate of 90% (18/20) during the first three months following VATS. The patient groups presenting the best response to VATS denervation were those with electrical storms 100% (N = 6/6) resolution, and those with prior ablation therapy 92% (N = 11/12) resolution. Although most of these patients did not have long-term follow-up, this study shows considerable results in the immediate post-op and short-term periods during the months following cardiac denervation in those whom follow-up was possible.
Patients suffering from refractory ventricular arrhythmias and electrical storms are high risk patients with exhausted treatment options. VATS cardiac denervation offers both a safe and effective last resort option for these patients with positive short-term outcomes. VATS sympathectomy, a thoracic surgical solution to a medical cardiological problem, may benefit these high-risk patients extending their therapeutic options. Taking into consideration the comorbidities and high sudden cardiac death risk in these patients, long-term follow-up is not always possible limiting the number of cases available in the literature. Additional research is warranted to assess long-term results. Small sample size and short follow-up periods were the primary limitations of this study.
Bilateral thoracoscopic cardiac denervation can be a safe and effective therapeutic option for patients suffering from life-threatening refractory ventricular arrhythmias and Electrical Storms secondary to different cardiomyopathies including Chagas disease. However, because of variable results in the literature, further controlled studies and long-term follow-up is necessary to determine optimal technique effectiveness.
English Revisions by: Dr. Richard Resin; and Dr. Bernardo Herrera
No funding was provided.
Availability of data and materials
All authors contributed to the development of this article. All authors read and approved the final manuscript.
Ethics approval and consent to participate
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
- 4.MERCHANT NN, Onugha O. Vats Sympathectomy for refractory ventricular arrhythmias: is it helpful? J Cardiol Cardiovasc Ther. 2017;8(5):555747.Google Scholar
- 6.Te Riele AS, Ajijola OA, Shivkumar K, Tandri H. Role of bilateral sympathectomy in the treatment of refractory ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Arrhythm Electrophysiol 2016;9(4):e003713.Google Scholar
- 11.Richardson T, Lugo R, Saavedra P, Crossley G, Clair W, Shen S, Estrada JC, Montgomery J, Shoemaker MB, Ellis C, Michaud GF. Cardiac sympathectomy for the management of ventricular arrhythmias refractory to catheter ablation. Heart rhythm. 2018;15(1):56–62.Google Scholar
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.